Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Isaptent--a new cervical dilator

N M Khanna, J P Sarin, R C Nandi

    Contraception
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anti-Viral Activity of Indian Plants.

    Proceedings of the National Academy of Sciences, India. Section B·2020
    Same author

    INDUCTION OF SECOND TRIMESTER ABORTION BY INTRAAMNIOTIC ADMINISTRATION OF 15(S)15 METHYL PGF<sub>2α</sub>.

    Acta obstetricia et gynecologica Scandinavica·2017
    Same author

    ADJUNCTIVE USE OF LAMINARIA TENT WITH INTRAMUSCULAR 15(S)15 METHYL PGF<sub>2α</sub> FOR INDUCTION OF SECOND TRIMESTER ABORTION.

    Acta obstetricia et gynecologica Scandinavica·2017
    Same author

    DOSE RESPONSE RELATIONSHIP OF NEUROMUSCULAR BLOCKADE, INTUBATION CONDITIONS AND CARDIOVASCULAR CHANGES WITH CHANDONIUM IODIDE.

    Medical journal, Armed Forces India·2017
    Same author

    The distribution of zinc in the subcellular fractions of the rhesus monkey testis.

    Biological trace element research·2013
    Same author

    Indian Pharmacological Society: A SWOT analysis.

    Indian journal of pharmacology·2011
    Same journal

    Reasons patients decide to replace or extend their long-acting reversible contraceptive before the full duration of pregnancy prevention: a qualitative study.

    Contraception·2026
    Same journal

    Awareness of abortion medications by mail options among abortion patients at 6 clinics: Findings from a pilot study.

    Contraception·2026
    Same journal

    A phase 1, randomized, open-label, single-dose relative bioavailability study of upper arm injection of depot medroxyprogesterone acetate comparing pharmacokinetics and hormone indicators of ovulation with anterior thigh and abdomen injection.

    Contraception·2026
    Same journal

    Associations between pharmacy type, neighborhood disadvantage, and availability and accessibility of an over-the-counter oral contraceptive pill in three Michigan counties.

    Contraception·2026
    Same journal

    Previous caesarean section and major complications during surgical abortion: a national multicentre case-control study.

    Contraception·2026
    Same journal

    Quantification of residual levonorgestrel following extended use of the levonorgestrel 52 mg intrauterine device beyond 8 years.

    Contraception·2026
    See all related articles

    A novel cervical dilator, Isaptent, derived from Plantago ovata seed husk, effectively dilated the cervix in 94% of women undergoing medical termination of pregnancy. This natural method showed no adverse effects on the cervix or vaginal flora.

    Area of Science:

    • Obstetrics and Gynecology
    • Medical Devices
    • Natural Product Therapeutics

    Background:

    • Cervical dilatation is crucial for procedures like medical termination of pregnancy.
    • Existing methods for cervical dilatation can have limitations and side effects.
    • Plantago ovata (Isapgol) seed husk is a natural material with potential absorbent properties.

    Purpose of the Study:

    • To evaluate the efficacy and safety of Isaptent, a novel cervical dilator made from Plantago ovata seed husk.
    • To compare the performance of Isaptent with existing cervical dilatation methods.
    • To assess the impact of Isaptent on cervical tissue and vaginal flora.

    Main Methods:

    • A multicentric clinical trial involving 804 women aged 15-45 years with gestations from 8-24 weeks.

    Related Experiment Videos

  • Single Isaptent device used for cervical dilatation in 750 subjects.
  • Assessment of dilatation success, cervical integrity, and vaginal flora through bacteriologic studies.

    • Main Results:

    • Satisfactory cervical dilatation was achieved in 94% of cases using a single Isaptent.
    • Cervical dilatation was independent of patient age, parity, and gestational period.
    • Isaptent demonstrated self-lubricating properties and caused no apparent cervical damage; vaginal flora remained unchanged.

    Conclusions:

    • Isaptent is a safe and effective cervical dilator for medical termination of pregnancy.
    • The natural composition of Isaptent offers advantages over synthetic or surgical methods.
    • Further research can explore Isaptent's utility in other gynecological procedures requiring cervical dilatation.